Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 April 2006, Vol. 107, No. 7, pp. 2976-2983.
Prepublished online as a Blood First Edition Paper on November 29, 2005; DOI 10.1182/blood-2005-06-2562.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-06-2562v1
107/7/2976    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ni, H.
Right arrow Articles by Freedman, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ni, H.
Right arrow Articles by Freedman, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted June 29, 2005
Accepted November 16, 2005

A novel murine model of fetal and neonatal alloimmune thrombocytopenia:Response to intravenous IgG therapy

Heyu Ni*, Pingguo Chen, Christopher M Spring, Ebrahim Sayeh, John W Semple, Alan H Lazarus, Richard O Hynes, and John Freedman

Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Canadian Blood Services, Canada; The Toronto Platelet Immunobiology Group, St. Michael's Hospital, Toronto, Ontario, Canada
Canadian Blood Services, Canada; The Toronto Platelet Immunobiology Group, St. Michael's Hospital, Toronto, Ontario, Canada
The Toronto Platelet Immunobiology Group, St. Michael's Hospital, Toronto, Ontario, Canada
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; The Toronto Platelet Immunobiology Group, St. Michael's Hospital, Toronto, Ontario, Canada; Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada
Howard Hughes Medical Institute and Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; The Toronto Platelet Immunobiology Group, St. Michael's Hospital, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada

* Corresponding author; email: nih{at}smh.toronto.on.ca.

Fetal and neonatal alloimmune thrombocytopenia (FNAITP) is a life-threatening bleeding disorder caused by maternal antibodies directed against fetal platelet antigens. The immunoreactive epitopes in FNAITP are primarily located in the extracellular regions of the platelet glycoprotein IIIa ({beta}3 integrin). Here we have established a novel animal model of FNAITP using {beta}3 integrin-deficient ({beta}3-/-) mice. We demonstrated first that these mice are immunoresponsive to {beta}3 integrin; {beta}3-/- mice transfused with wild-type platelets generated specific anti-{beta}3 antibodies which were able to induce thrombocytopenia in wild-type mice. Subsequently {beta}3-/- female mice (both naive and immunized) were bred with wild-type male mice to recapitulate the features of FNAITP. The titer of generated maternal antibodies correlated with the severity of FNAITP. High titer maternal anti-{beta}3 antibodies caused severe fetal thrombocytopenia, intracranial hemorrhage, and even miscarriage. Furthermore, maternal administration of intravenous IgG ameliorated FNAITP and downregulated pathogenic antibodies in both the maternal and fetal circulations.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
W. Nishie, D. Sawamura, K. Natsuga, S. Shinkuma, M. Goto, A. Shibaki, H. Ujiie, E. Olasz, K. B. Yancey, and H. Shimizu
A Novel Humanized Neonatal Autoimmune Blistering Skin Disease Model Induced by Maternally Transferred Antibodies
J. Immunol., September 15, 2009; 183(6): 4088 - 4093.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Reheman, H. Yang, G. Zhu, W. Jin, F. He, C. M. Spring, X. Bai, P. L. Gross, J. Freedman, and H. Ni
Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor
Blood, February 19, 2009; 113(8): 1809 - 1817.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020